fbpx

Programme

Expand All +

  • Main Summit: Thursday 19 March 2020

     

  • Pre-Summit Workshops: Wednesday 18 March 2020

     

  • Dr Ware will dispell myths about THC, the most researched cannabinoid for therapeutic benefits.

     

    Medicine/CPD

     

  • Dr Spelman will help you understand the science behind plant constituents, and review the pharmacokinetics and pharmacodynamics of cannabis, which will enable a better understand of how to use cannabis in a clinical setting.

     

    Medicine/CPD
    Industry
    Science

     

  • Get an overview of pharmaceutical cannabis including safety, clinical evidence, pharmacology, pharmacokinetics, interactions, contraindications and dosage forms.

     

    Medicine/CPD

     

  • Understand the development of clinical trials and programs for pharmaceutical cannabis for multiple therapeutic indications for public health benefit.

     

    Science

     

  • Learn about the options, current industrial practice and future trends for the extraction of cannabis.

     

    Industry

     

  • Hear Tom Forrest’s reflection on the challenges and opportunities from the cultivation perspective.

     

    Industry

     

  • Hear from the Goodfather of cannabis on areas of future scientific research

     

    Science

     

  • How to use medicinal cannabis in real world practice, including how to use it to treat chronic pain, anxiety, insominia and opioid overuse.

     

    Medicine/CPD

     

  • Understand the history of cannabis and the current issues with regards to the stigma of cannabis.

     

    Medicine/CPD

     

  • Hear about the use of natural product scaffolds for the development of new drugs for epilepsy, neuropathic pain, depression, anxiety, substance abuse, and schizophrenia.

     

    Science

     

  • Patients will share their experiences of using medicinal cannabis.

     

    Medicine/CPD
    Policy

     

  • Hear Dr Washer’s perspective on the unexpected journey from biotech to cannabis medicine and back again.

     

    Industry

     

  • Hear from the Goodfather on medicinal cannabis use in the clinical setting.

     

    Medicine/CPD

     

  • Learn the chemistry of cannabis, including the cannabinoids, trepenoids and flavonoids.

     

    Science

     

  • Hear how international regulation could impact the New Zealand medicinal cannabis industry.

     

    Industry

     

  • As medicinal cannabis is a new industry for New Zealand, how can we learn from other countries about regulation?

     

    Industry

     

  • The panel will discuss case studies of medicinal cannabis clinical trials.

     

    Science

     

  • Gain an understanding of intellectual property, including infringement risk, how to avoid losing valuable IP, and how to identify important IP assets such as patents, trademarks, know-how and copyrights.

     

    Science

     

  • Learn about patients perspective on cannabis use, the data collected on effectiveness and adverse effects of medicinal cannabis.

     

    Science

     

  • Learn about the implications of prescribing medicinal cannabis in New Zealand from 1 April 2020 as outlined in the new Medicinical Cannabis Regulations.

     

    Medicine/CPD

     

  • Dr Arboleda will share current evidence and practical experience in how cannabiniod-based medicines are being use to treat chronic pain and in palliative care management.

     

    Medicine/CPD

     

  • Understand the primary business principles required to initiate and grow a successful business within the emerging cannabis industry.

     

    Industry

     

  • This talk lays the groundwork of the endocannabinoid system (deficiency syndrome), synthetics, phytocannabinoids (plant, cannabinoids CBD vs CB2, terpenes) delivery mechanisms and contraindications

     

    Medicine/CPD
    Science

     

  • Hear from the Goodfather of cannabis, Raphael Mechoulam, who has been studying THC and CBD for more than 30 years.

     

    Medicine/CPD

     

  • Learn about the guidelines for cultivating medicinal cannabis in New Zealand from 1 April 2020.

     

    Industry

     

  • Lunch, exhibition and networking

     

  • Round table discussions facilitated by experts covering the following topics;
    Growing, Processing and Manufacturing, Quality and Testing, Formulation & Regulations

     

    Industry

     

  • Round table discussions facilitated by experts covering the following topics;
    Growing, Processing and Manufacturing, Quality and Testing, Formulation & Regulations

     

    Industry
    Science
    Technology

     

  • Facilitator & Asia/Pacific – Martin Woodbridge, International Consultant, Woodbridge Research
    USA/Canada – Brent Zettl, President and CEO, ZYUS Life Sciences Inc.
    Recent emerging environments – Rhys Cohen, Principal Consultant, FreshLeaf Analytics
    Colombia, Mexico, Peru, Argentina, Chile, Brazil, Canada – Dr Maria-Fernanda Arboleda MD, International Director Medical Services, Khiron Life Sciences Corp

     

    Medicine/CPD
    Industry
    NZ Economy
    Policy
    Science
    Technology

     

  • The role of clinical trials and evidence-based medicine in the medicinal cannabis sector and New Zealand’s role

     

    Medicine/CPD

     

  • Meet and discuss with industry along the supply chain seed to sale

     

    Industry
    Science
    Technology